US FDA launches fresh safety scrutiny of approved RSV therapies for infants
U.S. well being regulators knowledgeable senior executives at Merck, Sanofi and AstraZeneca final week that their approved protecting RSV remedies for infants would face fresh safety scrutiny following considerations raised…